The Anti-Inflammation and Anti-Nociception Effect of Ketoprofen in Rats Could Be Strengthened Through Co-Delivery of a H2S Donor, S-Propargyl-Cysteine
Yue Yu,1,* Qinyan Yang,1,* Zhou Wang,1 Qian Ding,1 Meng Li,1 Yudong Fang,1 Qida He,1 Yi Zhun Zhu1,2 1State Key Laboratory of Quality Research in Chinese Medicine & School of Pharmacy, Macau University of Science and Technology, Taipa, Macau SAR, People’s Republic of China; 2Shang...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/b1884374f0fc45389b4b5444719e23c0 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:b1884374f0fc45389b4b5444719e23c0 |
|---|---|
| record_format |
dspace |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
h2s donor ketoprofen adjuvant induced arthritis anti-inflammation analgesic effect Pathology RB1-214 Therapeutics. Pharmacology RM1-950 |
| spellingShingle |
h2s donor ketoprofen adjuvant induced arthritis anti-inflammation analgesic effect Pathology RB1-214 Therapeutics. Pharmacology RM1-950 Yu Y Yang Q Wang Z Ding Q Li M Fang Y He Q Zhu YZ The Anti-Inflammation and Anti-Nociception Effect of Ketoprofen in Rats Could Be Strengthened Through Co-Delivery of a H2S Donor, S-Propargyl-Cysteine |
| description |
Yue Yu,1,* Qinyan Yang,1,* Zhou Wang,1 Qian Ding,1 Meng Li,1 Yudong Fang,1 Qida He,1 Yi Zhun Zhu1,2 1State Key Laboratory of Quality Research in Chinese Medicine & School of Pharmacy, Macau University of Science and Technology, Taipa, Macau SAR, People’s Republic of China; 2Shanghai Key Laboratory of Bioactive Small Molecules & School of Pharmacy, Fudan University, Shanghai, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yi Zhun ZhuMacau University of Science and Technology, Block E, Avenida Wai Long, Taipa, Macau SAR, 999078, People’s Republic of ChinaTel +853 8897 2880Fax +853 2882 3575Email yzzhu@must.edu.moPurpose: Ketoprofen (KETO) is a traditional non-steroidal anti-inflammatory drug (NSAIDs) with good analgesic and antipyretic effects. However, as NASIDs, the toxicity of KETO towards gastrointestinal (GI) system might limit its clinical use. S-propargyl-cysteine (SPRC) is an excellent endogenous H2S donor showed wide application in the field of anti-inflammation, anti-oxidative stress, or even the protection of cardiovascular system through the elevation of endogenous H2S concentration. As recently studies reported, co-administration of H2S donor might potentially mitigate the GI toxicity and relevant side effects induced by series of NSAIDs.Methods: In this study, we established a SPRC and KETO co-encapsulated poly (lactic-co-glycolic acid) microsphere (SK@MS), and its particle size, morphology, storage stability and in vitro release profile were firstly investigated. The elevation of endogenous H2S level of SK@MS was then calculated, and the pharmacodynamic study (anti-inflammation and analgesic effects) of SK@MS, SPRC, and KETO towards adjuvant induced arthritis (AIA) in rats were also studied. Finally, to test the potential side effect, the heart, liver, spleen, lung, kidney, stomach, small intestine, and large intestine were resected from rats and examined by H&E staining.Results: A monodispersed SK@MS could be observed under the SEM, and particle size was calculated around 25.12 μm. The loading efficiency (LE) for SPRC and KETO were 6.67% and 2.64%, respectively, while the encapsulation efficiency (EE) for SPRC and KETO were 37.20% and 68.28%, respectively. SK@MS showed a sustained release of SPRC and KETO in vitro, which was up-to 15 days. SK@MS could achieve a long-term elevation of the H2S concentration in vivo, while SPRC showed an instant H2S elevation and metabolize within 6 h. Interestingly, the KETO did not show any influence on the H2S concentration in vivo. After establishment of AIA model, neither SPRC nor KETO showed scarcely anti-inflammation and anti-nociception effect, while conversely, SK@MS showed an obvious mitigation towards paw edema and pain in AIA rats, which indicated an improved anti-inflammation and anti-nociception effect when co-delivery of SRC and KETO. Besides, low stimulation towards major organs in rats observed in any experimental group.Conclusion: A monodispersed was successfully prepared in this study, and SK@MS showed a sustained SPRC and KETO release in vitro and H2S release in vivo. In the pharmacodynamics study, SK@MS not only exhibited an excellent anti-inflammation and analgesic effects in AIA rats but also showed low stimulation towards rats.Keywords: H2S donor, ketoprofen, adjuvant induced arthritis, anti-inflammation, analgesic effect |
| format |
article |
| author |
Yu Y Yang Q Wang Z Ding Q Li M Fang Y He Q Zhu YZ |
| author_facet |
Yu Y Yang Q Wang Z Ding Q Li M Fang Y He Q Zhu YZ |
| author_sort |
Yu Y |
| title |
The Anti-Inflammation and Anti-Nociception Effect of Ketoprofen in Rats Could Be Strengthened Through Co-Delivery of a H2S Donor, S-Propargyl-Cysteine |
| title_short |
The Anti-Inflammation and Anti-Nociception Effect of Ketoprofen in Rats Could Be Strengthened Through Co-Delivery of a H2S Donor, S-Propargyl-Cysteine |
| title_full |
The Anti-Inflammation and Anti-Nociception Effect of Ketoprofen in Rats Could Be Strengthened Through Co-Delivery of a H2S Donor, S-Propargyl-Cysteine |
| title_fullStr |
The Anti-Inflammation and Anti-Nociception Effect of Ketoprofen in Rats Could Be Strengthened Through Co-Delivery of a H2S Donor, S-Propargyl-Cysteine |
| title_full_unstemmed |
The Anti-Inflammation and Anti-Nociception Effect of Ketoprofen in Rats Could Be Strengthened Through Co-Delivery of a H2S Donor, S-Propargyl-Cysteine |
| title_sort |
anti-inflammation and anti-nociception effect of ketoprofen in rats could be strengthened through co-delivery of a h2s donor, s-propargyl-cysteine |
| publisher |
Dove Medical Press |
| publishDate |
2021 |
| url |
https://doaj.org/article/b1884374f0fc45389b4b5444719e23c0 |
| work_keys_str_mv |
AT yuy theantiinflammationandantinociceptioneffectofketoprofeninratscouldbestrengthenedthroughcodeliveryofah2sdonorspropargylcysteine AT yangq theantiinflammationandantinociceptioneffectofketoprofeninratscouldbestrengthenedthroughcodeliveryofah2sdonorspropargylcysteine AT wangz theantiinflammationandantinociceptioneffectofketoprofeninratscouldbestrengthenedthroughcodeliveryofah2sdonorspropargylcysteine AT dingq theantiinflammationandantinociceptioneffectofketoprofeninratscouldbestrengthenedthroughcodeliveryofah2sdonorspropargylcysteine AT lim theantiinflammationandantinociceptioneffectofketoprofeninratscouldbestrengthenedthroughcodeliveryofah2sdonorspropargylcysteine AT fangy theantiinflammationandantinociceptioneffectofketoprofeninratscouldbestrengthenedthroughcodeliveryofah2sdonorspropargylcysteine AT heq theantiinflammationandantinociceptioneffectofketoprofeninratscouldbestrengthenedthroughcodeliveryofah2sdonorspropargylcysteine AT zhuyz theantiinflammationandantinociceptioneffectofketoprofeninratscouldbestrengthenedthroughcodeliveryofah2sdonorspropargylcysteine AT yuy antiinflammationandantinociceptioneffectofketoprofeninratscouldbestrengthenedthroughcodeliveryofah2sdonorspropargylcysteine AT yangq antiinflammationandantinociceptioneffectofketoprofeninratscouldbestrengthenedthroughcodeliveryofah2sdonorspropargylcysteine AT wangz antiinflammationandantinociceptioneffectofketoprofeninratscouldbestrengthenedthroughcodeliveryofah2sdonorspropargylcysteine AT dingq antiinflammationandantinociceptioneffectofketoprofeninratscouldbestrengthenedthroughcodeliveryofah2sdonorspropargylcysteine AT lim antiinflammationandantinociceptioneffectofketoprofeninratscouldbestrengthenedthroughcodeliveryofah2sdonorspropargylcysteine AT fangy antiinflammationandantinociceptioneffectofketoprofeninratscouldbestrengthenedthroughcodeliveryofah2sdonorspropargylcysteine AT heq antiinflammationandantinociceptioneffectofketoprofeninratscouldbestrengthenedthroughcodeliveryofah2sdonorspropargylcysteine AT zhuyz antiinflammationandantinociceptioneffectofketoprofeninratscouldbestrengthenedthroughcodeliveryofah2sdonorspropargylcysteine |
| _version_ |
1718376400501604352 |
| spelling |
oai:doaj.org-article:b1884374f0fc45389b4b5444719e23c02021-12-02T19:36:19ZThe Anti-Inflammation and Anti-Nociception Effect of Ketoprofen in Rats Could Be Strengthened Through Co-Delivery of a H2S Donor, S-Propargyl-Cysteine1178-7031https://doaj.org/article/b1884374f0fc45389b4b5444719e23c02021-11-01T00:00:00Zhttps://www.dovepress.com/the-anti-inflammation-and-anti-nociception-effect-of-ketoprofen-in-rat-peer-reviewed-fulltext-article-JIRhttps://doaj.org/toc/1178-7031Yue Yu,1,* Qinyan Yang,1,* Zhou Wang,1 Qian Ding,1 Meng Li,1 Yudong Fang,1 Qida He,1 Yi Zhun Zhu1,2 1State Key Laboratory of Quality Research in Chinese Medicine & School of Pharmacy, Macau University of Science and Technology, Taipa, Macau SAR, People’s Republic of China; 2Shanghai Key Laboratory of Bioactive Small Molecules & School of Pharmacy, Fudan University, Shanghai, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yi Zhun ZhuMacau University of Science and Technology, Block E, Avenida Wai Long, Taipa, Macau SAR, 999078, People’s Republic of ChinaTel +853 8897 2880Fax +853 2882 3575Email yzzhu@must.edu.moPurpose: Ketoprofen (KETO) is a traditional non-steroidal anti-inflammatory drug (NSAIDs) with good analgesic and antipyretic effects. However, as NASIDs, the toxicity of KETO towards gastrointestinal (GI) system might limit its clinical use. S-propargyl-cysteine (SPRC) is an excellent endogenous H2S donor showed wide application in the field of anti-inflammation, anti-oxidative stress, or even the protection of cardiovascular system through the elevation of endogenous H2S concentration. As recently studies reported, co-administration of H2S donor might potentially mitigate the GI toxicity and relevant side effects induced by series of NSAIDs.Methods: In this study, we established a SPRC and KETO co-encapsulated poly (lactic-co-glycolic acid) microsphere (SK@MS), and its particle size, morphology, storage stability and in vitro release profile were firstly investigated. The elevation of endogenous H2S level of SK@MS was then calculated, and the pharmacodynamic study (anti-inflammation and analgesic effects) of SK@MS, SPRC, and KETO towards adjuvant induced arthritis (AIA) in rats were also studied. Finally, to test the potential side effect, the heart, liver, spleen, lung, kidney, stomach, small intestine, and large intestine were resected from rats and examined by H&E staining.Results: A monodispersed SK@MS could be observed under the SEM, and particle size was calculated around 25.12 μm. The loading efficiency (LE) for SPRC and KETO were 6.67% and 2.64%, respectively, while the encapsulation efficiency (EE) for SPRC and KETO were 37.20% and 68.28%, respectively. SK@MS showed a sustained release of SPRC and KETO in vitro, which was up-to 15 days. SK@MS could achieve a long-term elevation of the H2S concentration in vivo, while SPRC showed an instant H2S elevation and metabolize within 6 h. Interestingly, the KETO did not show any influence on the H2S concentration in vivo. After establishment of AIA model, neither SPRC nor KETO showed scarcely anti-inflammation and anti-nociception effect, while conversely, SK@MS showed an obvious mitigation towards paw edema and pain in AIA rats, which indicated an improved anti-inflammation and anti-nociception effect when co-delivery of SRC and KETO. Besides, low stimulation towards major organs in rats observed in any experimental group.Conclusion: A monodispersed was successfully prepared in this study, and SK@MS showed a sustained SPRC and KETO release in vitro and H2S release in vivo. In the pharmacodynamics study, SK@MS not only exhibited an excellent anti-inflammation and analgesic effects in AIA rats but also showed low stimulation towards rats.Keywords: H2S donor, ketoprofen, adjuvant induced arthritis, anti-inflammation, analgesic effectYu YYang QWang ZDing QLi MFang YHe QZhu YZDove Medical Pressarticleh2s donorketoprofenadjuvant induced arthritisanti-inflammationanalgesic effectPathologyRB1-214Therapeutics. PharmacologyRM1-950ENJournal of Inflammation Research, Vol Volume 14, Pp 5863-5875 (2021) |